183 related articles for article (PubMed ID: 31154196)
1. Racial differences in long-term outcomes among black and white patients with drug-eluting stents.
Sullivan LT; Mulder H; Chiswell K; Shaw LK; Wang TY; Jackson LR; Thomas KL
Am Heart J; 2019 Aug; 214():46-53. PubMed ID: 31154196
[TBL] [Abstract][Full Text] [Related]
2. Differences in short-term versus long-term outcomes of older black versus white patients with myocardial infarction: findings from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of American College of Cardiology/American Heart Association Guidelines (CRUSADE).
Mathews R; Chen AY; Thomas L; Wang TY; Chin CT; Thomas KL; Roe MT; Peterson ED
Circulation; 2014 Aug; 130(8):659-67. PubMed ID: 25002016
[TBL] [Abstract][Full Text] [Related]
3. Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
Giustino G; Harari R; Baber U; Sartori S; Stone GW; Leon MB; Windecker S; Serruys PW; Kastrati A; Von Birgelen C; Kimura T; Stefanini GG; Dangas GD; Wijns W; Steg PG; Morice MC; Camenzind E; Weisz G; Smits PC; Sorrentino S; Sharma M; Farhan S; Faggioni M; Kandzari D; Galatius S; Jeger RV; Valgimigli M; Itchhaporia D; Mehta L; Kim HS; Chieffo A; Mehran R
JAMA Cardiol; 2017 Aug; 2(8):855-862. PubMed ID: 28658478
[TBL] [Abstract][Full Text] [Related]
4. [Impact of prolonging dual antiplatelet therapy on long-term prognosis of elderly patients with coronary heart disease complicated with diabetes mellitus undergoing drug-eluting stent implantation].
Xu JJ; Zhu P; Song Y; Yuan DS; Jia SD; Zhao XY; Yao Y; Jiang L; Xu N; Li JX; Zhang Y; Song L; Gao LJ; Chen JL; Qiao SB; Yang YJ; Xu B; Gao RL; Yuan JQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 May; 50(5):450-457. PubMed ID: 35589593
[No Abstract] [Full Text] [Related]
5. Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
Sorrentino S; Claessen BE; Chandiramani R; Guedeney P; Vogel B; Baber U; Rau V; Wang J; Krucoff M; Kozuma K; Ge J; Seth A; Makkar R; Liu Y; Bangalore S; Bhatt DL; Angiolillo DJ; Saito S; Neumann FJ; Hermiller J; Valgimigli M; Mehran R
Circulation; 2020 Mar; 141(11):891-901. PubMed ID: 31992063
[TBL] [Abstract][Full Text] [Related]
6. Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention.
Cai A; Dillon C; Hillegass WB; Beasley M; Brott BC; Bittner VA; Perry GJ; Halade GV; Prabhu SD; Limdi NA
J Am Heart Assoc; 2019 Nov; 8(22):e012874. PubMed ID: 31701784
[TBL] [Abstract][Full Text] [Related]
7. Gender differences and bleeding complications after PCI on first and second generation DES.
Wanha W; Kawecki D; Roleder T; Pluta A; Marcinkiewicz K; Morawiec B; Kret M; Pawlowski T; Smolka G; Ochala A; Wojakowski W
Scand Cardiovasc J; 2017 Feb; 51(1):53-60. PubMed ID: 27471987
[TBL] [Abstract][Full Text] [Related]
8. Comparison of long-term safety and efficacy outcomes after drug-eluting and bare-metal stent use across racial groups: Insights from NHLBI Dynamic Registry.
Olafiranye O; Vlachos H; Mulukutla SR; Marroquin OC; Selzer F; Kelsey SF; Williams DO; Strollo PJ; Reis SE; Lee JS; Smith AJC
Int J Cardiol; 2015 Apr; 184():79-85. PubMed ID: 25697874
[TBL] [Abstract][Full Text] [Related]
9. Incidence, nature, and temporal trends of adverse events associated with noncardiac procedures among veterans with drug-eluting coronary artery stents.
Salters C; Bradley B; Charnigo RJ; Shah Z; Meehan J; Abdel-Latif A; Ziada KM
Catheter Cardiovasc Interv; 2015 Aug; 86(2):211-9. PubMed ID: 25323046
[TBL] [Abstract][Full Text] [Related]
10. Racial Differences in Quality of Care and Outcomes After Acute Coronary Syndrome.
Yong CM; Ungar L; Abnousi F; Asch SM; Heidenreich PA
Am J Cardiol; 2018 Jun; 121(12):1489-1495. PubMed ID: 29655881
[TBL] [Abstract][Full Text] [Related]
11. Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
Yu J; Mehran R; Baber U; Ooi SY; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Brodie BR; Stuckey TD; Maehara A; Xu K; Ben-Yehuda O; Kirtane AJ; Stone GW
Circ Cardiovasc Interv; 2017 Feb; 10(2):. PubMed ID: 28193677
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
[TBL] [Abstract][Full Text] [Related]
13. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963
[TBL] [Abstract][Full Text] [Related]
14. Comparative Outcomes After Percutaneous Coronary Intervention Among Black and White Patients Treated at US Veterans Affairs Hospitals.
Kobayashi T; Glorioso TJ; Armstrong EJ; Maddox TM; Plomondon ME; Grunwald GK; Bradley SM; Tsai TT; Waldo SW; Rao SV; Banerjee S; Nallamothu BK; Bhatt DL; Rene AG; Wilensky RL; Groeneveld PW; Giri J
JAMA Cardiol; 2017 Sep; 2(9):967-975. PubMed ID: 28724126
[TBL] [Abstract][Full Text] [Related]
15. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
16. Borderline trend towards long-term mortality benefit from drug eluting stents implantation in ST-elevation myocardial infarction patients in Poland-data from NRDES registry.
Siudak Z; Dziewierz A; Rakowski T; Żmudka K; Legutko J; Bartuś S; Dragan J; Zasada W; Tokarek T; Kułaga T; Partyka Ł; Dudek D
Catheter Cardiovasc Interv; 2014 Feb; 83(3):436-42. PubMed ID: 24038740
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: the XIMA Trial (Xience or Vision Stents for the Management of Angina in the Elderly).
de Belder A; de la Torre Hernandez JM; Lopez-Palop R; O'Kane P; Hernandez Hernandez F; Strange J; Gimeno F; Cotton J; Diaz Fernandez JF; Carrillo Saez P; Thomas M; Pinar E; Curzen N; Baz JA; Cooter N; Lozano I; Skipper N; Robinson D; Hildick-Smith D;
J Am Coll Cardiol; 2014 Apr; 63(14):1371-5. PubMed ID: 24216285
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of intravascular ultrasound-guided implantation of bare metal stents versus drug-eluting stents in primary percutaneous coronary intervention.
Cho YK; Hur SH; Park NH; Choi SW; Sohn JH; Cho HO; Park HS; Yoon HJ; Kim H; Nam CW; Kim YN; Kim KB
Korean J Intern Med; 2014 Jan; 29(1):66-75. PubMed ID: 24574835
[TBL] [Abstract][Full Text] [Related]
19. Impact of chronic kidney disease on long-term clinical outcomes after percutaneous coronary intervention with drug-eluting or bare-metal stents.
Kersting S; Grumann T; Hummel J; Hauschke D; Bode C; Hehrlein C
Crit Pathw Cardiol; 2012 Sep; 11(3):152-9. PubMed ID: 22825536
[TBL] [Abstract][Full Text] [Related]
20. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography.
Gonzalo N; Barlis P; Serruys PW; Garcia-Garcia HM; Onuma Y; Ligthart J; Regar E
JACC Cardiovasc Interv; 2009 May; 2(5):445-52. PubMed ID: 19463469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
